Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2009
11/05/2009US20090274713 Cross-linkers and their uses
11/05/2009US20090274656 Hepatitis c virus inhibitors
11/05/2009US20090274652 Hepatitis C Virus Inhibitors
11/05/2009US20090273277 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/05/2009CA2723042A1 Disubstituted phthalazine hedgehog pathway antagonists
11/05/2009CA2722923A1 Indazole compounds as ccr1 receptor antagonists
11/05/2009CA2722813A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/05/2009CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009CA2722648A1 Aminopyridine derivatives
11/05/2009CA2722577A1 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators
11/05/2009CA2722347A1 Piperidine and pyrrolidine compounds
11/04/2009EP2113503A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/04/2009EP2113501A1 5-Methyl-1-(naphthalen-2-YL)-1H-Pyrazoles useful as sigma receptor inhibitors
11/04/2009EP2112880A2 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
11/04/2009EP1931341B1 1h-indole-pyridinecarboxamide and 1h-indole-piperidinecarboxamide derivatives and their use as tyrosine hydroxylase inducers
11/04/2009EP1734038B1 Nitrogenous heterocycle derivative and organic electroluminescent element employing the same
11/04/2009EP1720868B1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/04/2009EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/04/2009EP1615613B1 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2009EP1553092B1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
11/04/2009EP1533304B1 Amide derivative
11/04/2009EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009EP1446387B1 Substituted aryl 1,4-pyrazine derivatives
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009EP1303488B1 Piperidine compounds for use as ccr-3 inhibitors
11/04/2009CN101573354A Substituted isoquinolines and their use as Rho-kinase inhibitors
11/04/2009CN101573353A Substituted isoquinoline and isoquinolinone derivatives
11/04/2009CN101573343A HIV inhibiting 6-substituted pyrimidines
11/04/2009CN101573342A HIV inhibiting 5,6-substituted pyrimidines
11/04/2009CN101573339A Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
11/04/2009CN101573336A Chemical compounds
11/04/2009CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/03/2009US7612201 Pyrazole compounds
11/03/2009US7612103 Such as 14-O-[4-hydroxy-N-valyl-piperidin-3-yl]-sulfanylacetylmutilin
11/03/2009US7612100 Anthranilamides, process for the production thereof, and pest controllers containing the same
11/03/2009US7612099 Such as 3-[(5-Fluoro-3-methyl-1H-indol-2-yl)-phenyl-methyl]-4-hydroxy-5-isopropyl-1,5-dihydro-pyrrol-2-one which inhibits chymase
11/03/2009US7612098 Amorphous hydrous esomeprazole magnesium
11/03/2009US7612097 Microbiocidal; cost efficiency; industrial scale
11/03/2009US7612095 Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612091 Caspase inhibitors and uses thereof
11/03/2009US7612090 Use in treatment of a disorder which is created by or is dependent upon decreased availability of serotonin, norepinephrine or dopamine
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009US7612070 Indole derivative having heterocycle and mono- or diazaindole derivative
11/03/2009US7612068 (S)-1-{2-[2-(4-Fluoro-phenylsulfanyl)-phenoxy]-ethyl}-pyrrolidine-2-carboxylic acid; glycine transport inhibitors; for schizophrenia and other psychoses
11/03/2009US7612065 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors; Parkinson's disease
11/03/2009US7612064 Sulfopyrroles
11/03/2009US7612060 (R)-3-((1-((R)-7-cyclopropylaminomethyl-3,4-dihydro-2H-chromen-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-methylbenzenesulfonyl)-3,4-dihydropyrazin-2(1H)-one; pain, inflammation
11/03/2009US7612059 Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
11/03/2009US7612010 Manganese, titanium, iron, cobalt, nickel and/or copper coordinated with triring linked pyridinyl and pyrimidinyl or triazinyl ligands; peroxide activators; low temperature efficiency
11/03/2009US7611909 Near infrared chemiluminescent acridinium compounds and uses thereof
11/03/2009CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/03/2009CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
11/03/2009CA2341291C Pyridine ketones useful as herbicides
10/2009
10/29/2009WO2009132136A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009WO2009132000A1 Quinoline or isoquinoline substituted p2x7 antagonists
10/29/2009WO2009131814A2 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands
10/29/2009WO2009131687A2 Inhibitors of protein kinases
10/29/2009WO2009131669A2 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009WO2009131196A1 Substituted pyrrolidine derivative and use thereof
10/29/2009WO2009131173A1 2-aminoquinazoline derivative
10/29/2009WO2009131129A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009WO2009131127A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130900A1 Oxime derivative, intermediate compound, and plant disease control agent
10/29/2009WO2009130496A1 Substituted pyrimidin-5-carboxamides 281
10/29/2009WO2009130481A1 Pyrrole antifungal agents
10/29/2009WO2009130331A1 5-methyl-1-(naphthalen-2-yl)-1h-pyrazoles useful as sigma receptor inhibitors
10/29/2009WO2009130310A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
10/29/2009WO2009130240A1 Isoquinolinone derivatives as nk3 antagonists
10/29/2009WO2009130234A1 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity
10/29/2009WO2009130193A1 Fungicide hydroximoyl-heterocycles derivatives
10/29/2009WO2009129945A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
10/29/2009WO2009129696A1 A kind of receptor signaling transoluction positive modulators, preparation methods and uses thereof
10/29/2009WO2009129625A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/29/2009WO2009129573A1 Nicotinamide derivatives
10/29/2009WO2009106980A3 Indazole derivatives
10/29/2009WO2008142528A9 An improved process for preparing nevirapine
10/29/2009US20090270627 4-Ethynyl (1,2-dicyanobenzene)-4'-Ethynylphenyl-1(4,5-dicyanobenzene); 1,4-Bis(4-pyridyl)butadiyne; 4-ethynyl(pyridine)-4'-ethynylnaphthalene-1-pyridine; self-assembled mono-, multilayers/ supramolecular objects; three-terminal devices; logic switches;nanoelectronic ; computers; wires; dielectrics
10/29/2009US20090270623 Process for production of cinnamide derivative
10/29/2009US20090270621 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
10/29/2009US20090270613 5-Fluoro-4-methyl-2-{2-[4-(4-methyl-piperazin-1-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; leukocyte recruitment inhibition, modulating H4 receptor, and treating conditions such as inflammation
10/29/2009US20090270611 Benzoimidazole compounds
10/29/2009US20090270589 Bis-Terpyridine Monomer, Production Process Thereof, Polymer Material Derived from the Monomer, and Electrochromic Device
10/29/2009US20090270462 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors
10/29/2009US20090270461 N-cyclopropyl-N-[(3,4-dimethoxypyridin-2-yl)methyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide; control of phytopathogenic fungi of plants
10/29/2009US20090270460 Fxr agonists
10/29/2009US20090270458 Method of treating of demyelinating diseases or conditions
10/29/2009US20090270454 Sulfonamide containing compounds for treatment of inflammatory disorders
10/29/2009US20090270451 Piperdine Glycine Transporter Inhibitors
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090270436 Spirochromanon derivatives
10/29/2009US20090270434 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/29/2009US20090270416 N-OXIDES OF DIARYLUREA DERIVATIVES AND THEIR USE AS Chk1 INHIBITORS FOR THE TREATMENT OF CANCER
10/29/2009US20090270414 2,3,4,9- tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
10/29/2009US20090270411 Phenanthridine derivatives as bradykinin antagonists
1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 1080